购物车
- 全部删除
- 您的购物车当前为空
CCF0058981 (CCF981) 是3-氯苯基类似物,是一种非共价 SARS-CoV-2 3CLpro(SC2)抑制剂,IC50为 68 nM。CCF0058981 抑制 SC1 (SARS-CoV-1 3CLpro),IC50为 19 nM。CCF0058981 具有抗病毒功效,具有用于 COVID-19 研究的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
CCF0058981 (CCF981) 是3-氯苯基类似物,是一种非共价 SARS-CoV-2 3CLpro(SC2)抑制剂,IC50为 68 nM。CCF0058981 抑制 SC1 (SARS-CoV-1 3CLpro),IC50为 19 nM。CCF0058981 具有抗病毒功效,具有用于 COVID-19 研究的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 383 | 现货 | |
5 mg | ¥ 942 | 现货 | |
10 mg | ¥ 1,630 | 现货 | |
25 mg | ¥ 3,430 | 现货 | |
50 mg | ¥ 4,720 | 现货 | |
100 mg | ¥ 6,360 | 现货 |
产品描述 | CCF0058981 (CCF981) is a 3-chlorophenyl analogue, serving as a noncovalent inhibitor of SARS-CoV-2 3CL pro (SC2), demonstrating potent activity with an IC50 of 68 nM. It also exhibits inhibitory effects against SARS-CoV-1 3CL pro (SC1) with an IC50 of 19 nM, highlighting its antiviral efficacy and potential in COVID-19 research [1]. |
体外活性 | CCF0058981 (CCF981) exhibits cytopathic effect (CPE) inhibition (EC 50 =497 nM) and plaque reduction (EC 50 =558 nM) in vitro viral replication [1]. CCF0058981 has the 50% cytotoxic concentration (CC 50 ) in the CPE antiviral assay of >50 μM [1]. CCF0058981 has a T 1/2 of 21.1 min, a CL lnt of 141 mL/min kg in Human liver microsomes [1]. |
分子量 | 442.9 |
分子式 | C24H19ClN6O |
CAS No. | 2708934-53-4 |
Smiles | C(C(N(CC1=CC(Cl)=CC=C1)C2=CC=C(C=C2)C3=CN=CN3)=O)N4C=5C(N=N4)=CC=CC5 |
密度 | 1.37 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
溶解度信息 | DMSO: 1 mg/mL (2.26 mM), Sonication is recommended. ![]() | ||||||||||
溶液配制表 | |||||||||||
DMSO
|
评论内容